184 related articles for article (PubMed ID: 38416506)
1. Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.
Baumrin E; Shin DB; Mitra N; Pidala J; El Jurdi N; Lee SJ; Loren AW; Gelfand JM
JAMA Dermatol; 2024 Apr; 160(4):393-401. PubMed ID: 38416506
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease.
Baumrin E; Baker LX; Byrne M; Martin PJ; Flowers ME; Onstad L; El Jurdi N; Chen H; Beeghly-Fadiel A; Lee SJ; Tkaczyk ER
JAMA Dermatol; 2023 Apr; 159(4):393-402. PubMed ID: 36884224
[TBL] [Abstract][Full Text] [Related]
3. Hand grip strength and 2-minute walk test in chronic graft-versus-host disease assessment: analysis from the Chronic GVHD Consortium.
Pidala J; Chai X; Martin P; Inamoto Y; Cutler C; Palmer J; Weisdorf D; Pavletic S; Arora M; Jagasia M; Jacobsohn D; Lee SJ
Biol Blood Marrow Transplant; 2013 Jun; 19(6):967-72. PubMed ID: 23542686
[TBL] [Abstract][Full Text] [Related]
4. Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.
El-Jawahri A; Pidala J; Inamoto Y; Chai X; Khera N; Wood WA; Cutler C; Arora M; Carpenter PA; Palmer J; Flowers M; Weisdorf D; Pavletic S; Jaglowski S; Jagasia M; Lee SJ; Chen YB
Biol Blood Marrow Transplant; 2014 Sep; 20(9):1341-8. PubMed ID: 24813171
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.
Pidala J; Kurland B; Chai X; Majhail N; Weisdorf DJ; Pavletic S; Cutler C; Jacobsohn D; Palmer J; Arai S; Jagasia M; Lee SJ
Blood; 2011 Apr; 117(17):4651-7. PubMed ID: 21355084
[TBL] [Abstract][Full Text] [Related]
7. Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease.
Cardones AR; Sullivan KM; Green C; Chao NJ; Rowe-Nichols K; Bañez LL; Burton CS; Horwitz ME; Long GD; Rao CL; Sarantopoulos S; Sidhu-Malik N; Sung AD; Hall RP
JAMA Dermatol; 2019 Jul; 155(7):833-837. PubMed ID: 30994873
[TBL] [Abstract][Full Text] [Related]
8. Translation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian Population.
Vasconcellos de Souza C; Vigorito AC; Miranda ECM; Garcia C; Rensi Colturato VA; Mauad MA; Rodrigues Moreira MC; da Silva Bouzas LF; Lermontov S; Hamerschlak N; Rodrigues M; Carlos de Almeida Barros J; Chiattone R; Lee SJ; Flowers MED
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1313-1318. PubMed ID: 27058616
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium.
Pidala J; Kurland BF; Chai X; Vogelsang G; Weisdorf DJ; Pavletic S; Cutler C; Majhail N; Lee SJ
Haematologica; 2011 Oct; 96(10):1528-35. PubMed ID: 21685473
[TBL] [Abstract][Full Text] [Related]
10. Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life.
Sun YC; Chai X; Inamoto Y; Pidala J; Martin PJ; Flowers ME; Shen TT; Lee SJ; Jagasia M
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1687-91. PubMed ID: 26033283
[TBL] [Abstract][Full Text] [Related]
11. Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes.
Hamilton BK; Rybicki L; Arai S; Arora M; Cutler CS; Flowers MED; Jagasia M; Martin PJ; Palmer J; Pidala J; Majhail NS; Lee SJ; Khera N
Biol Blood Marrow Transplant; 2018 Feb; 24(2):393-399. PubMed ID: 29032275
[TBL] [Abstract][Full Text] [Related]
12. Coping and Modifiable Psychosocial Factors are Associated with Mood and Quality of Life in Patients with Chronic Graft-versus-Host Disease.
Jacobs JM; Fishman S; Sommer R; Sereno I; Fenech A; Jankowski AL; Traeger L; Greer JA; Vanderklish J; Hunnewell C; Saylor M; Chen YB; Spitzer T; DeFilipp Z; Temel JS; El-Jawahri A
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2234-2242. PubMed ID: 31260800
[TBL] [Abstract][Full Text] [Related]
13. Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium.
Jacobsohn DA; Kurland BF; Pidala J; Inamoto Y; Chai X; Palmer JM; Arai S; Arora M; Jagasia M; Cutler C; Weisdorf D; Martin PJ; Pavletic SZ; Vogelsang G; Lee SJ; Flowers ME
Blood; 2012 Sep; 120(13):2545-52; quiz 2774. PubMed ID: 22773386
[TBL] [Abstract][Full Text] [Related]
14. A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-Disease.
Patel SS; Hong S; Rybicki L; Farlow S; Dabney J; Kalaycio M; Sobecks R; Majhail NS; Hamilton BK
Transplant Cell Ther; 2023 Jul; 29(7):465.e1-465.e7. PubMed ID: 37003415
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Patient-Reported Outcomes with Clinical Organ Responses: Data from the Belumosudil Chronic Graft-versus-Host Disease Studies.
Lee SJ; Cutler C; Blazar BR; Tu A; Yang Z; Pavletic SZ
Transplant Cell Ther; 2022 Oct; 28(10):700.e1-700.e6. PubMed ID: 35781099
[TBL] [Abstract][Full Text] [Related]
16. Genetic risk factors for sclerotic graft-versus-host disease.
Inamoto Y; Martin PJ; Flowers ME; Lee SJ; Carpenter PA; Warren EH; Geraghty DE; Lee N; Boeckh MJ; Storer BE; Levine DM; Fan W; Zhao LP; Hansen JA
Blood; 2016 Sep; 128(11):1516-24. PubMed ID: 27313329
[TBL] [Abstract][Full Text] [Related]
17. Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease.
Palmer J; Chai X; Pidala J; Inamoto Y; Martin PJ; Storer B; Pusic I; Flowers ME; Arora M; Pavletic SZ; Lee SJ
Blood; 2016 Jan; 127(1):160-6. PubMed ID: 26527676
[TBL] [Abstract][Full Text] [Related]
18. Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.
Guru Murthy GS; Kim S; Hu ZH; Estrada-Merly N; Abid MB; Aljurf M; Bacher U; Badawy SM; Beitinjaneh A; Bredeson C; Cahn JY; Cerny J; Diaz Perez MA; Farhadfar N; Gale RP; Ganguly S; Gergis U; Hildebrandt GC; Grunwald MR; Hashmi S; Hossain NM; Kalaycio M; Kamble RT; Kharfan-Dabaja MA; Hamilton BK; Lazarus HM; Liesveld J; Litzow M; Marks DI; Murthy HS; Nathan S; Nazha A; Nishihori T; Patel SS; Pawarode A; Rizzieri D; Savani B; Seo S; Solh M; Ustun C; van der Poel M; Verdonck LF; Vij R; Wirk B; Oran B; Nakamura R; Scott B; Saber W
JAMA Oncol; 2022 Mar; 8(3):404-411. PubMed ID: 35024768
[TBL] [Abstract][Full Text] [Related]
19. Chronic cutaneous graft-versus-host disease in children: A report of 14 patients from a tertiary care pediatric dermatology clinic.
Nanda A; Husain MAA; Al-Herz W; Almekaimi A; Al-Sabah H; Al-Otaibi M
Pediatr Dermatol; 2018 May; 35(3):343-353. PubMed ID: 29536565
[TBL] [Abstract][Full Text] [Related]
20. Validation of measurement scales in ocular graft-versus-host disease.
Inamoto Y; Chai X; Kurland BF; Cutler C; Flowers ME; Palmer JM; Carpenter PA; Heffernan MJ; Jacobsohn D; Jagasia MH; Pidala J; Khera N; Vogelsang GB; Weisdorf D; Martin PJ; Pavletic SZ; Lee SJ;
Ophthalmology; 2012 Mar; 119(3):487-93. PubMed ID: 22153706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
